Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-08-11 to 2025-08-12
Current total value of award: $5357.13
Description: 4569053793!QUILLIVANT XR ORAL SUSP 150ML 5MG/ML